Ab
Abcam (Danaher)
Cambridge UKFounded 19981,500 employees
Private CapbiotechAcquiredOncology
Platform: Ab Reagents
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Geliderotide | ABC-2228 | Phase 3 | 2 | KIF18A | MG | ||
| Olpaderotide | ABC-8385 | Phase 2 | 1 | BTK | Thymoma |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)